Dr. Levi Garraway, MD
Dr. Levi Garraway, MD is a medical oncologist in Boston, MA. He graduated from HARVARD Medical School in 1999. He is accepting new patients.
Practice
44 Binney St Boston, MA 02115Make an Appointment
Compare with other Medical Oncologists
Compare Dr. Garraway with our nearby Medical Oncologists at Tufts Medical Center.
Make an appointment at Tufts Medical Center today at
(617) 263-8322.
Experience Check
Search for experience in a specific area
Dr. Garraway's Reviews
Overall Patient Satisfaction
About Me
biography
Dr. Levi Garraway, MD is a medical oncologist in Boston, MA. He graduated from HARVARD Medical School in 1999. He is accepting new patients.Medical Oncology
Massachusetts General Hospital
Residency HospitalMassachusetts General Hospital
Internship HospitalHarvard Medical School
Medical School, 1999
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkThe landscape of somatic copy-number alteration across human cancers, 2010-02-18
Genetic mechanisms of immune evasion in colorectal cancer, 2018-03-06
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma, 2010-11-25
MicroSCALE Screening Reveals Genetic Modifiers of Therapeutic Response in Melanoma, 2012-05-15
Highly recurrentTERTpromoter mutations in human melanoma, 2013-01-24
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma, 2013-11-21
Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy, 2010-07-04
Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade, 2018-04-12
Sequence analysis of mutations and translocations across breast cancer subtypes, 2012-06-20
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition, 2013-11-03
Erratum to: Unraveling the clonal hierarchy of somatic genomic aberrations, 2017-05-02
RNF43 is frequently mutated in colorectal and endometrial cancers, 2014-10-26
Phenotypic characterization of a comprehensive set ofMAPK1/ERK2 missense mutants, 2016-10-18
Unraveling the clonal hierarchy of somatic genomic aberrations, 2014-08-26
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma, 2016-04-14
Genomic copy number dictates a gene-independent cell response to CRISPR-Cas9 targeting, 2016-06-03
AKT-independent signaling downstream of oncogenicPIK3CAmutations in human cancer, 2009-07-07
Melanoma genome sequencing reveals frequentPREX2mutations, 2012-05-09
The genomic complexity of primary human prostate cancer, 2011-02-10
COT/MAP3K8drives resistance to RAF inhibition through MAP kinase pathway reactivation, 2010-11-24
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq, 2016-04-08
Fusobacterium nucleatumand T-cells in Colorectal Carcinoma, 2015-08-01
Assessing the clinical utility of cancer genomic and proteomic data across tumor types, 2014-06-22
A Functional Landscape of Resistance to ALK Inhibition in Lung Cancer, 2015-03-09
An Integrated Approach to Uncover Drivers of Cancer, 2010-12-02
Discovery and saturation analysis of cancer genes across 21 tumor types, 2014-01-05
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer, 2012-05-20
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma, 2011-07-28
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T cell Therapy, 2018-04-05
Systematic genomic and translational efficiency studies of uveal melanoma, 2017-06-08
TRIM24 is an oncogenic transcriptional activator in prostate cancer, 2016-05-26
Mutational heterogeneity in cancer and the search for new cancer genes, 2013-06-16
Major copy proportion analysis of tumor samples using SNP arrays, 2008-04-21
Fusobacterium nucleatumin colorectal carcinoma tissue and patient prognosis, 2015-08-26
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples, 2009-11-18
Long-term benefit of PD-L1 blockade in lung cancer associated withJAK3activation, 2015-05-26
Focus on Breast Cancer
Insurance Check
Search for your insurance carrier and choose your plan type
Locations
Practice
Compare with other Medical Oncologists
Compare Dr. Garraway with our nearby Medical Oncologists at Tufts Medical Center.
Make an appointment at Tufts Medical Center today at
(617) 263-8322.